首頁 > 市場調查報告書 > 醫療設備

基因克隆和誘變的全球市場(2022年～2030年):市場佔有率，規模，趨勢，產業分析，各產品，各技術，各最終用途，各地區，市場區隔預測

市場調查報告書

商品編碼

1191434

基因克隆和誘變的全球市場(2022年～2030年):市場佔有率，規模，趨勢，產業分析，各產品，各技術，各最終用途，各地區，市場區隔預測

Cloning And Mutagenesis Market Share, Size, Trends, Industry Analysis Report, By Product (Cloning Kits, Mutagenesis Kits); By Technology; By End-use; By Region; Segment Forecast, 2022 - 2030

出版日期: 2022年12月01日 | 出版商:

Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球基因克隆和誘變的市場規模在2030年前將達到92億9,000萬美元。

本報告提供全球基因克隆和誘變市場調查，提供市場概要，市場的推動因素與阻礙因素的分析，市場機會，COVID-19影響，各市場區隔的市場分析，競爭情形，主要企業的簡介等系統性資訊。

產業的概述
市場動態
- 促進因素和機會
- 阻礙因素與課題
波特的五力分析
- 供給企業談判力(中)
- 新加入廠商者的威脅(低)
- 買方議價能力(中)
- 替代威脅(中)
- 現有企業間的競爭(高)
大環境分析
產業趨勢
價值鏈分析
COVID-19影響分析

第5章全球基因克隆和誘變市場:各產品

主要調查結果
簡介
- 各產品的全球市場(2018年～2030年)
基因複製套件
- 基因複製套件，各地區(2018年～2030年)
突然變異誘髮套件
- 突然變異誘髮套件，各地區(2018年～2030年)

第6章全球基因克隆和誘變市場:各技術

主要調查結果
簡介
- 各技術的全球市場(2018年～2030年)
TOPO PCR基因複製
- TOPO PCR基因複製，各地區(2018年～2030年)
部位特異性誘變
- 部位特異性誘變，各地區(2018年～2030年)

第7章全球基因克隆和誘變市場:各最終用途

主要調查結果
簡介
- 各最終用途全球市場(2018年～2030年)
生物醫藥品·製藥
- 生物醫藥品·製藥，各地區(2018年～2030年)
CRO·CMO
- CRO·CMO，各地區(2018年～2030年)

第8章全球基因克隆和誘變市場:各地區

主要調查結果
簡介
- 基因克隆和誘變市場評估:各地區(2018年～2030年)
北美
- 各產品(2018年～2030年)
- 各最終用途(2018年～2030年)
- 各技術(2018年～2030年)
- 美國
- 加拿大
歐洲
- 各產品(2018年～2030年)
- 各最終用途(2018年～2030年)
- 各技術(2018年～2030年)
- 英國
- 法國
- 德國
- 義大利
- 西班牙
- 荷蘭
- 俄羅斯
亞太地區
- 各產品(2018年～2030年)
- 各最終用途(2018年～2030年)
- 各技術(2018年～2030年)
- 中國
- 印度
- 馬來西亞
- 日本
- 印尼
- 韓國
中東·非洲
- 各產品(2018年～2030年)
- 各最終用途(2018年～2030年)
- 各技術(2018年～2030年)
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 南非
南美
- 各產品(2018年～2030年)
- 各最終用途(2018年～2030年)
- 各技術(2018年～2030年)
- 墨西哥
- 巴西
- 阿根廷

第9章競爭情形

擴張和收購的分析
- 擴張
- 收購
夥伴關係/合作/協定/展示會

第10章企業簡介

Agilent Technologies, Inc
Thermo Fisher Scientific, Inc
New England Biolabs
Takara Bio Inc
Merck KGaA
Promega Corporation
Bio-Rad Laboratories, Inc
Danaher
Jena Bioscience GmbH
Assay Genie
TransGen Biotech Co., Ltd

簡介目錄圖表

Product Code: PM2936

The global cloning and mutagenesis market size is expected to reach USD 9.29 billion by 2030, according to a new study by Polaris Market Research. The report "Cloning And Mutagenesis Market Share, Size, Trends, Industry Analysis Report, By Product (Cloning Kits, Mutagenesis Kits); By Technology; By End-use; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global increase in the DNA and gene cloning services market is driven by the advancement of DNA sequencing technology, its growing application in clinical diagnostics and drug discovery, and an increase in R&D spending. Forensics, reproductive health, customized medicine, biomarkers, and diagnostics are just a few fields in which DNA sequencing is used. Recent research has shown that next-generation sequencing (NGS) technology can quickly and economically find and characterize clinically relevant genetic variations across various genes in a single test. Companies are also providing sequencing services. For instance, in December 2020, Eurofins Genomics introduced cost-effective and optimized SARS-CoV-2 NGS services, enabling the sequencing of the whole viral genome.

The purpose of gene therapy is to treat diseases by modifying genetic material, such as deactivating faulty genes or exchanging a disease-causing gene for a healthy copy. Various illnesses are being treated with gene therapy efficiently. Gene therapy can treat conditions like AIDS, diabetes, cancer, and heart disease.

The market is driven by a strong product portfolio, increased investment by major players, a high prevalence of target diseases, and interest in novel & innovative therapies. However, high product development costs and strict management standards are projected to constrain the global market. Increased R&D spending by public and private institutions is anticipated to open up new prospects in the worldwide cloning and mutagenesis market.

The COVID-19 epidemic has benefited the global market because lockdown measures have been implemented in many nations, which has increased the use of PCR for the detection and analysis of particular gene sequences, which primarily utilizes oligonucleotides as a primer, functioning as a catalyst for industry expansion. Oligonucleotides are widely employed in the biopharmaceutical sector for dsDNA binding, aptamer creation, and allele-specific tests. Moreover, the market is anticipated to present attractive potential in the upcoming years due to the growing utilization of DNA computing, CRISPR gene editing, and mutagenesis investigations.

Cloning And Mutagenesis Market Report Highlights

In 2021, the TOPO PCR category dominated the market. TOPO PCR cloning is seeing increased use across a variety of end users, including pharmaceutical and biotech corporations and academic and research institutions.

The pharmaceutical and biopharmaceutical companies dominated the revenue in 2021. Pharmaceutical and biopharmaceutical companies are focusing on drug discovery and development due to the rise in disease frequency.

North America emerged as the largest regional share in 2021. This substantial percentage can be attributed to the increased demand for biotechnology techniques. Cloning and mutagenesis methods have also become more popular in the region as platforms based on genomic and proteomic data have grown.

The global players include Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., New England Biolabs, Takara Bio Inc., Merck KGaA, Promega Corporation, Bio-Rad Laboratories, Inc., Danaher, Jena Bioscience GmbH, Assay Genie, TransGen Biotech Co., Ltd.

Polaris Market Research has segmented the cloning and mutagenesis market report based on product, technology, end-use, and region:

Cloning And Mutagenesis, Product Outlook (Revenue - USD Billion, 2018 - 2030)

Cloning Kits

Mutagenesis Kits

Cloning And Mutagenesis, Technology Outlook (Revenue - USD Billion, 2018 - 2030)

TOPO PCR Cloning

Site-directed Mutagenesis

Cloning And Mutagenesis, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)

Biopharmaceuticals and pharmaceutical companies

CROs and CMOS

Cloning And Mutagenesis, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

North America

U.S

Canada

Europe

Germany

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Cloning And Mutagenesis Market Insights

4.1. Cloning And Mutagenesis - Industry Snapshot
4.2. Cloning And Mutagenesis Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising demand for genetically modified products
  - 4.2.1.2. Increasing demand for personalized medicine
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High maintenance cost associated with cloning and mutagenesis tools & instruments
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Cloning And Mutagenesis Market Industry Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Cloning And Mutagenesis Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
5.3. Cloning Kits
- 5.3.1. Global Cloning And Mutagenesis Market, by Cloning Kits, by Region, 2018 - 2030 (USD Billion)
5.4. Mutagenesis Kits
- 5.4.1. Global Cloning And Mutagenesis Market, by Mutagenesis Kits, by Region, 2018 - 2030 (USD Billion)

6. Global Cloning And Mutagenesis Market, by Technology

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
6.3. TOPO PCR Cloning
- 6.3.1. Global Cloning And Mutagenesis Market, by TOPO PCR Cloning, by Region, 2018 - 2030 (USD Billion)
6.4. Site-directed Mutagenesis
- 6.4.1. Global Cloning And Mutagenesis Market, by Site-directed Mutagenesis, by Region, 2018 - 2030 (USD Billion)

7. Global Cloning And Mutagenesis Market, by End-Use

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
7.3. Biopharmaceuticals and pharmaceutical companies
- 7.3.1. Global Cloning And Mutagenesis Market, by Biopharmaceuticals and pharmaceutical companies, by Region, 2018 - 2030 (USD Billion)
7.4. CROs and CMOs
- 7.4.1. Global Cloning And Mutagenesis Market, by CROs and CMOs, by Region, 2018 - 2030 (USD Billion)

8. Global Cloning And Mutagenesis Market, by Geography

8.1. Key findings
8.2. Introduction
- 8.2.1. Cloning And Mutagenesis Market Assessment, By Geography, 2018 - 2030 (USD Billion)
8.3. Cloning And Mutagenesis Market - North America
- 8.3.1. North America: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
- 8.3.2. North America: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.3.3. North America: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.3.4. Cloning And Mutagenesis Market - U.S.
  - 8.3.4.1. U.S.: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.3.4.2. U.S.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.3.4.3. U.S.: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.3.5. Cloning And Mutagenesis Market - Canada
  - 8.3.5.1. Canada: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.3.5.2. Canada.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.3.5.3. Canada: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.4. Cloning And Mutagenesis Market - Europe
- 8.4.1. Europe: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
- 8.4.2. Europe.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.4.3. Europe: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.4.4. Cloning And Mutagenesis Market - UK
  - 8.4.4.1. UK: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.4.4.2. UK.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.4.4.3. UK: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.4.5. Cloning And Mutagenesis Market - France
  - 8.4.5.1. France: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.4.5.2. France.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.4.5.3. France: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.4.6. Cloning And Mutagenesis Market - Germany
  - 8.4.6.1. Germany: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.4.6.2. Germany.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.4.6.3. Germany: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.4.7. Cloning And Mutagenesis Market - Italy
  - 8.4.7.1. Italy: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.4.7.2. Italy.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.4.7.3. Italy: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.4.8. Cloning And Mutagenesis Market - Spain
  - 8.4.8.1. Spain: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.4.8.2. Spain.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.4.8.3. Spain: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.4.9. Cloning And Mutagenesis Market - Netherlands
  - 8.4.9.1. Netherlands: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.4.9.2. Netherlands.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.4.9.3. Netherlands: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.4.10. Cloning And Mutagenesis Market - Russia
  - 8.4.10.1. Russia: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.4.10.2. Russia.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.4.10.3. Russia: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.5. Cloning And Mutagenesis Market - Asia Pacific
- 8.5.1. Asia Pacific: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
- 8.5.2. Asia Pacific.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.5.3. Asia Pacific: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.5.4. Cloning And Mutagenesis Market - China
  - 8.5.4.1. China: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.5.4.2. China.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.5.4.3. China: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.5.5. Cloning And Mutagenesis Market - India
  - 8.5.5.1. India: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.5.5.2. India.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.5.5.3. India: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.5.6. Cloning And Mutagenesis Market - Malaysia
  - 8.5.6.1. Malaysia: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.5.6.2. Malaysia.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.5.6.3. Malaysia: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.5.7. Cloning And Mutagenesis Market - Japan
  - 8.5.7.1. Japan: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.5.7.2. Japan.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.5.7.3. Japan: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.5.8. Cloning And Mutagenesis Market - Indonesia
  - 8.5.8.1. Indonesia: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.5.8.2. Indonesia.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.5.8.3. Indonesia: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.5.9. Cloning And Mutagenesis Market - South Korea
  - 8.5.9.1. South Korea: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.5.9.2. South Korea.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.5.9.3. South Korea: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.6. Cloning And Mutagenesis Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
- 8.6.2. Middle East & Africa.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.6.3. Middle East & Africa: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.6.4. Cloning And Mutagenesis Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.6.4.2. Saudi Arabia.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.6.5. Cloning And Mutagenesis Market - UAE
  - 8.6.5.1. UAE: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.6.5.2. UAE.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.6.5.3. UAE: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.6.6. Cloning And Mutagenesis Market - Israel
  - 8.6.6.1. Israel: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.6.6.2. Israel.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.6.6.3. Israel: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.6.7. Cloning And Mutagenesis Market - South Africa
  - 8.6.7.1. South Africa: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.6.7.2. South Africa.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.6.7.3. South Africa: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.7. Cloning And Mutagenesis Market - Latin America
- 8.7.1. Latin America: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
- 8.7.2. Latin America.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.7.3. Latin America: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.7.4. Cloning And Mutagenesis Market - Mexico
  - 8.7.4.1. Mexico: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.7.4.2. Mexico.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.7.4.3. Mexico: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.7.5. Cloning And Mutagenesis Market - Brazil
  - 8.7.5.1. Brazil: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.7.5.2. Brazil.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.7.5.3. Brazil: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.7.6. Cloning And Mutagenesis Market - Argentina
  - 8.7.6.1. Argentina: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.7.6.2. Argentina.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.7.6.3. Argentina: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Agilent Technologies, Inc
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Thermo Fisher Scientific, Inc
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. New England Biolabs
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Takara Bio Inc
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Merck KGaA
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Promega Corporation
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Bio-Rad Laboratories, Inc
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Danaher
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Jena Bioscience GmbH
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Assay Genie
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. TransGen Biotech Co., Ltd
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development

簡介目錄圖表

List of Tables

Table 1 Global Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 2 Global Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 3 Global Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 4 Cloning And Mutagenesis Market Assessment, By Geography, 2018 - 2030 (USD Billion)
Table 5 North America: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 6 North America: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 7 North America: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 8 U.S.: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 9 U.S.: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 10 U.S.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 11 Canada: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 12 Canada: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 13 Canada: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 14 Europe: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 15 Europe: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 16 Europe: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 17 UK: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 18 UK: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 19 UK: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 20 France: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 21 France: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 22 France: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 23 Germany: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 24 Germany: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 25 Germany: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 26 Italy: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 27 Italy: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 28 Italy: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 29 Spain: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 30 Spain: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 31 Spain: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 32 Netherlands: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 33 Netherlands: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 34 Netherlands: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 35 Russia: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 36 Russia: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 37 Russia: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 38 Asia Pacific: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 39 Asia Pacific: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 40 Asia Pacific: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 41 China: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 42 China: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 43 China: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 44 India: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 45 India: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 46 India: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 47 Malaysia: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 48 Malaysia: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 49 Malaysia: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 50 Japan: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 51 Japan: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 52 Japan: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 53 Indonesia: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 54 Indonesia: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 55 Indonesia: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 56 South Korea: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 57 South Korea: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 58 South Korea: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 59 Middle East & Africa: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 60 Middle East & Africa: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 61 Middle East & Africa: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 62 Saudi Arabia: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 63 Saudi Arabia: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 64 Saudi Arabia: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 65 UAE: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 66 UAE: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 67 UAE: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 68 Israel: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 69 Israel: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 70 Israel: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 71 South Africa: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 72 South Africa: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 73 South Africa: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 74 Latin America: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 75 Latin America: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 76 Latin America: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 77 Mexico: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 78 Mexico: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 79 Mexico: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 80 Brazil: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 81 Brazil: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 82 Brazil: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 83 Argentina: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 84 Argentina: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 85 Argentina: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)

List of Figures

Figure 1. Global Cloning And Mutagenesis Market, 2018 - 2030 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Technology
Figure 7. Global Cloning And Mutagenesis Market, by Technology, 2021 & 2030 (USD Billion)
Figure 8. Market by Product
Figure 9. Global Cloning And Mutagenesis Market, by Product, 2021 & 2030 (USD Billion)
Figure 10. Market by End-Use
Figure 11. Global Cloning And Mutagenesis Market, by End-Use, 2021 & 2030 (USD Billion)
Figure 12. Cloning And Mutagenesis Market Assessment, By Geography, 2018 - 2030 (USD Billion)
Figure 13. Strategic Analysis - Cloning And Mutagenesis Market